Ceribell, Inc. to Showcase Innovations at Health Care Event
Ceribell, Inc. (Nasdaq: CBLL), a pioneering medical technology company, is excited to announce its participation in an upcoming Health Care Conference hosted by Bank of America Securities. At this noteworthy event, Jane Chao, Ph.D., who serves as the CEO and Co-founder of Ceribell, will take the stage to present the company's innovative technologies targeted at improving patient outcomes in serious neurological conditions.
Event Details
Jane Chao's presentation at the Bank of America Securities Health Care Conference is scheduled for a Wednesday, where she will discuss advancements in medical technology that are crucial in transforming patient care. The specifics of the event are as follows:
Event: Bank of America Securities Health Care Conference
Date: A Wednesday in May
Time: 10:55 a.m. PST / 1:55 p.m. EST
What to Expect from Ceribell
Attendees can look forward to a detailed overview of the Ceribell System, a groundbreaking point-of-care electroencephalography (EEG) platform. This innovative system aims to meet the urgent needs of patients in acute care environments, particularly those experiencing neurological issues. The presentation by Dr. Chao will elaborate on how this system integrates proprietary hardware with advanced artificial intelligence (AI) algorithms, facilitating rapid diagnosis and continuous monitoring of critical patient conditions.
Introducing the Ceribell System
The Ceribell System has been a game changer in the hospital setting, particularly for patients at risk of seizures. With its FDA 510(k) clearance, it allows for quicker identification of suspected seizure activities, offering invaluable support to medical professionals in emergency rooms and intensive care units across the nation. This technology ensures that critical decisions can be made promptly, ultimately improving patient care and outcomes.
About Ceribell, Inc.
Ceribell is dedicated to innovating diagnosis and management approaches in the field of neurology. The company recognizes the high stakes involved in acute neurological conditions and has committed itself to delivering advanced solutions. By leveraging cutting-edge technology and ongoing research, Ceribell is poised to make a significant impact on how neurological conditions are treated and monitored.
Company Commitment to Innovation
Innovation lies at the heart of Ceribell's operations. The company has cultivated an environment that encourages continuous improvement and development of its technologies. As a leader in medical technology, Ceribell remains focused on enhancing patient care through its pioneering approaches and solutions that are both effective and accessible.
Stay Informed
Health care professionals and those interested in the field can stay updated on Ceribell’s advancements by visiting their official website. The event's presentation will also be available in the "Investor Relations" section of the Ceribell website, ensuring that stakeholders can access insights post-event.
Investor Relations Contact
For more information regarding investments and corporate queries, shareholders can reach out to Brian Johnston or Laine Morgan from the Gilmartin Group via email at Investors@ceribell.com.
Media Contact Information
Inquiries related to media and public relations can be directed to Corrie Rose at Press@ceribell.com.
Frequently Asked Questions
What is the main focus of Ceribell, Inc.?
Ceribell focuses on transforming the diagnosis and management of patients with serious neurological conditions through innovative technology.
Who is Jane Chao?
Jane Chao, Ph.D., is the CEO and Co-founder of Ceribell, Inc., leading the company's mission in the medical technology sector.
What is the Ceribell System?
The Ceribell System is a novel EEG platform designed for point-of-care diagnosis and continuous monitoring of patients in acute care settings.
Where can I find the presentation from the health care conference?
The presentation will be available on the Ceribell website in the "Investor Relations" section after the event.
How can I contact Ceribell for investor inquiries?
Investors can contact Brian Johnston or Laine Morgan at Investors@ceribell.com for any inquiries.
